The addition of the anti-viral drug telaprevir to a standard treatment for hepatitis C can shorten the duration of therapy and increase the number of patients who can be cured of their disease, according to the results of ...
Apr 30, 2009
1 / 5 (1)
0
(PhysOrg.com) -- A research project led by University of Notre Dame biologist Malcolm J. Fraser Jr. may soon lead to the eradication of dengue fever, a mosquito-borne viral disease that annually infects more ...
Apr 13, 2009
not rated yet
0
At least 200 million individuals are currently infected with hepatitis C virus (HCV) worldwide. Approximately 30%-50% of patients respond to interferon/ribavirin combination therapy. Response to interferon therapy depends ...
Mar 30, 2009
not rated yet
0
A new study suggests that previously noted low rates of successful hepatitis C virus (HCV) therapy in African Americans are in large part due to very early differences in the antiviral activity induced by interferon. The ...
Mar 20, 2009
not rated yet
0
During its career, the potentially fatal hepatitis C virus has banked its success on a rather unusual strategy: its limitations. Its inability to infect animals other than humans and chimpanzees has severely ...
Jan 28, 2009
5 / 5 (1)
0
The most effective treatment for hepatitis C fails in two-thirds of Hispanic patients but works for half of white patients, researchers reported Wednesday in a study that confirms ethnic disparities in the liver disease.
Jan 15, 2009
not rated yet
0
